Aclaris Therapeutics (ACRS) Other financing activities (2021 - 2026)
Aclaris Therapeutics (ACRS) recorded Other financing activities of $23,000 in Q2 2026, up 155.6% from $9,000 a year earlier but down 90.8% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Other financing activities (2021 - 2026) Analysis & Trends
On a TTM basis, Aclaris Therapeutics' Other financing activities came in at $435,000 as of Jun 30, 2026, down 30.6% year-over-year; for FY2025, it came in at $446,000, up 9.0% from FY2024.
- Annual Other financing activities has increased for three straight years, though with a four-year compound annual growth rate of -38.5% (FY2021 to FY2025).
- Across earlier years, Other financing activities came in at $409,000 in FY2024 (+301.0%), $102,000 in FY2023 (+200.0%), $34,000 in FY2022 (-98.9%) and $3.12 million in FY2021.
- Quarterly Other financing activities has ranged from $2,000 in Q4 2021 to $333,000 in Q4 2024 over the past five years.
- On a year-over-year basis, Other financing activities rose in two of the last five quarters, with growth averaging 95.4%.
- Peak year-over-year performance for Other financing activities in the last five years was growth of 400.0% in Q1 2025, against a decline of 99.8% in Q1 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Aclaris Therapeutics | 735.48 Mn | 735.48 Mn | 1.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23,000.00 |
| Mar 31, 2026 | 250,000.00 |
| Dec 31, 2025 | 162,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 275,000.00 |
| Dec 31, 2024 | 333,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Sep 30, 2022 | 11,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 84,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | 3.01 Mn |
API Access
Aclaris Therapeutics Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();